Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Real-World Systematic Analysis of Driver Mutations' Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting.
Terrenato I, Ercolani C, Di Benedetto A, Gallo E, Melucci E, Casini B, Rollo F, Palange A, Visca P, Pescarmona E, Melis E, Gallina F, Sacconi A, Cecere FL, Landi L, Cappuzzo F, Ciliberto G, Buglioni S. Terrenato I, et al. Among authors: palange a. Cancers (Basel). 2022 Jun 16;14(12):2971. doi: 10.3390/cancers14122971. Cancers (Basel). 2022. PMID: 35740637 Free PMC article.
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available.
Ercolani C, Di Benedetto A, Bonomo C, Visca P, Palange A, Assisi D, Forcella D, Terrenato I, Pescarmona E, Ciliberto G, Cecere FL, Cappuzzo F, Buglioni S. Ercolani C, et al. Among authors: palange a. J Clin Pathol. 2022 Dec;75(12):844-850. doi: 10.1136/jclinpath-2021-207726. Epub 2021 Aug 16. J Clin Pathol. 2022. PMID: 34400544 Free PMC article.
TRF2 as novel marker of tumor response to taxane-based therapy: from mechanistic insight to clinical implication.
Iachettini S, Terrenato I, Porru M, Di Vito S, Rizzo A, D'Angelo C, Petti E, Dinami R, Maresca C, Di Benedetto A, Palange A, Mulè A, Santoro A, Palazzo A, Fuso P, Stoppacciaro A, Vici P, Filomeno L, Di Lisa FS, Arcuri T, Krasniqi E, Fabi A, Biroccio A, Zizza P. Iachettini S, et al. Among authors: palange a. J Exp Clin Cancer Res. 2024 Mar 9;43(1):75. doi: 10.1186/s13046-024-02998-w. J Exp Clin Cancer Res. 2024. PMID: 38459559 Free PMC article.
Nanomedicines to treat rare neurological disorders: The case of Krabbe disease.
Moore TL, Pannuzzo G, Costabile G, Palange AL, Spanò R, Ferreira M, Graziano ACE, Decuzzi P, Cardile V. Moore TL, et al. Among authors: palange al. Adv Drug Deliv Rev. 2023 Dec;203:115132. doi: 10.1016/j.addr.2023.115132. Epub 2023 Oct 31. Adv Drug Deliv Rev. 2023. PMID: 37918668 Free article. Review.
Assessing Differential Particle Deformability under Microfluidic Flow Conditions.
Miali ME, Chien W, Moore TL, Felici A, Palange AL, Oneto M, Fedosov D, Decuzzi P. Miali ME, et al. Among authors: palange al. ACS Biomater Sci Eng. 2023 Jun 12;9(6):3690-3698. doi: 10.1021/acsbiomaterials.3c00120. Epub 2023 May 17. ACS Biomater Sci Eng. 2023. PMID: 37194468 Free PMC article.
39 results